A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.
de Boer
M J
MJ
Department of Cardiology, Ziekenhuis de Weezenlanden, Zwolle, The Netherlands.
van Hout
B A
BA
Liem
A L
AL
Suryapranata
H
H
Hoorntje
J C
JC
Zijlstra
F
F
D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000191:economics*; D016009:Chi-Square Distribution; D003362:Cost-Benefit Analysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D017048:Health Care Costs; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000191:economics / Q000628:therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000191:economics*
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators